Successful radiopeptide targeting of metastatic anaplastic meningioma: case report

A patient with anaplastic meningioma and lung metastases resistant to conventional treatment underwent radiopeptide therapy with 177Lu- DOTA-octreotate in our institute. The treatment resulted in significant improvement in patient's quality of life and inhibition of tumor progression. This case...

Full description

Saved in:
Bibliographic Details
Published in:Radiation oncology (London, England) England), 2011-08, Vol.6 (1), p.94-94, Article 94
Main Authors: Sabet, Amir, Ahmadzadehfar, Hojjat, Herrlinger, Ulrich, Wilinek, Winfried, Biersack, Hans-Jürgen, Ezziddin, Samer
Format: Article
Language:English
Subjects:
111In-DTPA-octreotide
18F-FDG-PET/CT
anaplastic meningioma
Blood-Brain Barrier
Case Report
Case studies
Coordination Complexes - pharmacology
Diagnosis
Disease Progression
Drug therapy
Female
Health aspects
Humans
Lung Neoplasms - pathology
Lung Neoplasms - secondary
Meningioma
Meningioma - pathology
Meningioma - radiotherapy
Middle Aged
Neoplasm Metastasis
Octreotide - analogs & derivatives
Octreotide - pharmacology
Positron-Emission Tomography - methods
Quality of Life
radio receptor therapy
Radiopharmaceuticals
Radiopharmaceuticals - pharmacology
Receptors, Peptide - chemistry
Tomography, Emission-Computed, Single-Photon - methods
Tomography, X-Ray Computed - methods
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A patient with anaplastic meningioma and lung metastases resistant to conventional treatment underwent radiopeptide therapy with 177Lu- DOTA-octreotate in our institute. The treatment resulted in significant improvement in patient's quality of life and inhibition of tumor progression. This case may eventually help to establish the value of radiopeptide therapy in patients with this rare condition.
ISSN:1748-717X
1748-717X
DOI:10.1186/1748-717X-6-94